Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2011, Article ID 424759, 6 pages
http://dx.doi.org/10.4061/2011/424759
Research Article

Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality

1Department of Cardiology, Leiden University Medical Center, C5-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands
2Department of Gerontology and Geriatrics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
3Interuniversity Cardiology Institute of the Netherlands (ICIN), 3501 DG Utrecht, The Netherlands
4Einthoven Laboratory for Experimental Vascular Medicine, 2333 ZA Leiden, The Netherlands
5Department of Biochemistry, Justus-Liebig-University, 35392 Giessen, Germany
6Department of Epidemiology & Department of Radiology, Erasmus MC University Medical Center, 3000 CA Rotterdam, The Netherlands
7Department of Medical Statistics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands
8Department of Cardiology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands
9Department of Cardiology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands
10Department of Cardiology, Academic Medical Center, 1100 DD Amsterdam, The Netherlands
11Molecular Epidemiology Section, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
12The Netherlands Consortium for Healthy Ageing, 2300 RC Leiden, The Netherlands
13The Durrer Center for Cardiogenetic Research, 1105 AZ Amsterdam, The Netherlands

Received 25 November 2010; Revised 28 April 2011; Accepted 6 May 2011

Academic Editor: Anna Bersano

Copyright © 2011 Stella Trompet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Römisch, A. Feußner, S. Vermöhlen, and H. A. Stöhr, “A protease isolated from human plasma activating factor vii independent of tissue factor,” Blood Coagulation and Fibrinolysis, vol. 10, no. 8, pp. 471–479, 1999. View at Google Scholar · View at Scopus
  2. J. Römisch, S. Vermöhlen, A. Feussner, and H. A. Stöhr, “The FVII activating protease cleaves single-chain plasminogen activators,” Haemostasis, vol. 29, no. 5, pp. 292–299, 2000. View at Google Scholar · View at Scopus
  3. J. Roemisch, A. Feussner, C. Nerlich, H. A. Stoehr, and T. Weimer, “The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP),” Blood Coagulation and Fibrinolysis, vol. 13, no. 5, pp. 433–441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Gulesserian, G. Hron, G. Endler, S. Eichinger, O. Wagner, and P. A. Kyrle, “Marburg I polymorphism for factor VII-activating protease and risk of recurrent venous thromboembolism,” Thrombosis and Haemostasis, vol. 95, no. 1, pp. 65–67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Hoppe, F. Tolou, H. Radtke, H. Kiesewetter, T. Dörner, and A. Salama, “Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism,” Blood, vol. 105, no. 4, pp. 1549–1551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Hoppe, F. Tolou, T. Döner, H. Kiesewetter, and A. Salama, “Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population,” Thrombosis and Haemostasis, vol. 96, no. 4, pp. 465–470, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Ireland, G. J. Miller, K. E. Webb, J. A. Cooper, and S. E. Humphries, “The factor VII activating protease G511E (Marburg) variant and cardiovascular risk,” Thrombosis and Haemostasis, vol. 92, no. 5, pp. 986–992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Willeit, S. Kiechl, T. Weimer et al., “Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis,” Circulation, vol. 107, no. 5, pp. 667–670, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Kannemeier, N. Al-Fakhri, K. T. Preissner, and S. M. Kanse, “Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells,” The FASEB Journal, vol. 18, no. 6, pp. 728–730, 2004. View at Google Scholar · View at Scopus
  10. D. Sedding, J. M. Daniel, L. Muhl et al., “The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation,” Journal of Experimental Medicine, vol. 203, no. 13, pp. 2801–2807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Kanse, M. Parahuleva, L. Muhl, B. Kemkes-Matthes, D. Sedding, and K. T. Preissner, “Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis,” Thrombosis and Haemostasis, vol. 99, no. 2, pp. 286–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Shepherd, G. J. Blauw, M. B. Murphy et al., “The design of a prospective study of pravastatin in the elderly at risk (PROSPER),” American Journal of Cardiology, vol. 84, no. 10, pp. 1192–1197, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Shepherd, G. J. Blauw, M. B. Murphy et al., “Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial,” Lancet, vol. 360, no. 9346, pp. 1623–1630, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. W. R. P. Agema, P. S. Monraats, A. H. Zwinderman et al., “Current PTCA practice and clinical outcomes in the Netherlands: the real world in the pre-drug-eluting stent era,” European Heart Journal, vol. 25, no. 13, pp. 1163–1170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Ikram, S. Seshadri, J. C. Bis et al., “Genomewide association studies of stroke,” New England Journal of Medicine, vol. 360, no. 17, pp. 1718–1728, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Van Minkelen, M. C. H. De Visser, H. L. Vos et al., “The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis,” Blood, vol. 105, no. 12, pp. 4898–4899, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Parahuleva, S. M. Kanse, B. Parviz et al., “Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques,” Atherosclerosis, vol. 196, no. 1, pp. 164–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Melcon and M. O. Melcon, “Prevalence of stroke in an Argentine community,” Neuroepidemiology, vol. 27, no. 2, pp. 81–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Sagui, P. S. M'Baye, C. Dubecq et al., “Ischemic and hemorrhagic strokes in Dakar, Senegal: a hospital-based study,” Stroke, vol. 36, no. 9, pp. 1844–1847, 2005. View at Publisher · View at Google Scholar · View at Scopus